InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: LonghornSean post# 27873

Thursday, 08/05/2021 5:49:54 PM

Thursday, August 05, 2021 5:49:54 PM

Post# of 36558
J+J was less of a winner in COVID compared to PFE and MRNA due to the media exaggerated BP issue with older females in their vaccine. It was better and had easier logistics with No need for the sub-zero storage and transportation.

J+J is also more of a 'local drug store' recognized name. They may want a Big and FAST SPLASH with lots of MEDIA and a focus beyond the vaccinated US (etc), IMO.
Good Interim data May be enough to start it, IMO.

A Safe PILL for non-Hospitalized Patients at your local store...GLTA...


PS. Cancer Mabs are fine when there are few choices for life, just like a serious COVID patient. Their effectiveness is not universal as seen by recent FDA limitations on the uses for Keytruda/Yervoy/Optivo. Remdesevir (virs) have their dark sides too. But mabs as a vaccine for everyone? Hmmmm.

I took my shots early as I was 'high risk' and have done all those cancer drugs including Interferon, 4X survivor. I was not worried about side effects. Many younger folks may have different views.
My psyc was supported by regular Pot use and 'liberty caps' on occasion.

Come On J+J. Grab this market with Buc.